Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors
NCT02240966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2016-07-14
Summary
The purpose of this study is to investigate the prevalence of signs and symptoms of hypogonadism in three groups of testicular cancer survivors.
Conditions
- Metabolic Syndrome
- Hypogonadism
- Cardio-vascular Disease
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Gedske Daugaard, DMSc · Rigshospitalet, Denmark
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- Denmark
Study Locations
More Related Trials
-
Physical Exercise as a Sustainability Tool in Men With Dysmetabolic Hypogonadism
NCT06094036 ·Status: RECRUITING ·Phase: NA
-
Diurnal Testosterone Concentration
NCT03091296 ·Status: COMPLETED
-
Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients
NCT00965341 ·Status: COMPLETED ·Phase: PHASE3
-
BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC
NCT05530395 ·Status: NOT_YET_RECRUITING
-
Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction
NCT02803073 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
NCT03716739 ·Status: COMPLETED ·Phase: PHASE2
-
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
NCT03063125 ·Status: COMPLETED
-
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
NCT04049331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Testosterone, Cognition, Ageing, and Cancer
NCT03452436 ·Status: COMPLETED
-
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs
NCT04630275 ·Status: COMPLETED
-
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality
NCT04492553 ·Status: COMPLETED ·Phase: PHASE2
-
Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment
NCT02034487 ·Status: COMPLETED
-
Testosterone Undecanoate and Quality of Life of Men and Spouses
NCT01758029 ·Status: UNKNOWN
-
Survey of Testosterone Levels in Male Cancer Patients
NCT00483418 ·Status: COMPLETED
-
Autonomic Manifestations of Testosterone Deficiency in Men
NCT02715713 ·Status: WITHDRAWN
-
Hypogonadism in Young Men With Type 2 Diabetes
NCT01155518 ·Status: TERMINATED ·Phase: PHASE2
-
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
NCT01699178 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism
NCT02728440 ·Status: COMPLETED
-
Testosterone and Major Depression
NCT00286546 ·Status: COMPLETED
-
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
NCT02159469 ·Status: COMPLETED ·Phase: PHASE3
-
Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone
NCT03484260 ·Status: COMPLETED
-
Study of Testosterone vs Placebo in Testicular Cancer Survivors
NCT02991209 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
NCT07278362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene
NCT02651688 ·Status: COMPLETED ·Phase: PHASE2
-
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
NCT04731376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1